Rapid Micro Biosystems, Inc. (RPID) Financial Statements
Industry: Laboratory Analytical Instruments
In fiscal 2025, Rapid Micro Biosystems reported revenue of $33.6M, up 19.7% from $28.1M the year before. Net income was -$47.1M (a -140.3% net margin), or -$1.05 per diluted share. Gross margin was -141.1% and operating margin was -141.1%. Operating activities generated -$31.1M of cash, leaving -$31.9M of free cash flow. At fiscal year end, Rapid Micro Biosystems held $74.9M in total assets against $41.6M in total liabilities, including $20.0M of cash and equivalents.
Open the full interactive Rapid Micro Biosystems financials → Quarterly statements, key ratios, valuation history and price charts.
Rapid Micro Biosystems Key Stats
| Share Price | $0.87 |
|---|---|
| Market Cap | $42.3M |
| Revenue YoY Growth | +19.7% |
| 52-Week Range | $0.86 – $4.68 |
| Shares Outstanding | 48.3 million (basic, 2026 Q2) |
Rapid Micro Biosystems Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Cost of Goods Sold | $70.5M | $80.4M | $79.1M | $78.0M | $81.0M |
| Gross Profit | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| Operating Income | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| Pre-Tax Income | -$73.4M | -$61.4M | -$52.4M | -$46.9M | -$47.1M |
| Income Tax | $91,000 | -$576,000 | $31,000 | $22,000 | $40,000 |
| Net Income | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| Diluted EPS | -$3.94 | -$1.43 | -$1.22 | -$1.08 | -$1.05 |
Rapid Micro Biosystems Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $7.8M | $11.3M | $8.0M | $8.1M |
| Net Income | -$11.5M | -$12.5M | -$14.3M | -$12.9M |
| Diluted EPS | -$0.26 | -$0.28 | -$0.31 | -$0.27 |
Rapid Micro Biosystems Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $178.4M | $27.1M | $24.3M | $16.9M | $20.0M |
| Current Assets | $218.1M | $138.6M | $120.4M | $80.9M | $61.2M |
| Total Assets | $241.2M | $190.7M | $143.5M | $98.2M | $74.9M |
| Current Liabilities | $18.2M | $19.1M | $19.0M | $17.6M | $18.5M |
| Total Long-Term Debt | — | — | — | — | $18.9M |
| Total Liabilities | $20.2M | $26.5M | $25.5M | $22.8M | $41.6M |
| Shareholders' Equity | $221.0M | $164.2M | $118.0M | $75.4M | $33.2M |
Rapid Micro Biosystems Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$55.0M | -$58.5M | -$45.1M | -$44.2M | -$31.1M |
| Cash From Investing | -$13.3M | -$93.5M | $42.2M | $36.7M | $14.3M |
| Cash From Financing | $216.7M | $693,000 | $149,000 | $203,000 | $19.8M |
| Free Cash Flow | -$58.2M | -$65.3M | -$46.9M | -$45.5M | -$31.9M |
Figures from Rapid Micro Biosystems' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Rapid Micro Biosystems financials page for every line item.
Rapid Micro Biosystems Company Profile
| Ticker | RPID |
|---|---|
| Exchange | Nasdaq |
| Industry | Laboratory Analytical Instruments |
| Headquarters | Lexington, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001380106 |
Frequently Asked Questions
What was Rapid Micro Biosystems' revenue in fiscal 2025?
Rapid Micro Biosystems (RPID) reported revenue of $33.6M for fiscal 2025.
What is Rapid Micro Biosystems' annual revenue history?
Rapid Micro Biosystems' annual revenue by fiscal year: 2021: $23.2M; 2022: $17.1M; 2023: $22.5M; 2024: $28.1M; 2025: $33.6M.
What was Rapid Micro Biosystems' net income in fiscal 2025?
Rapid Micro Biosystems reported net income of -$47.1M for fiscal 2025.
What was Rapid Micro Biosystems' earnings per share (EPS) in fiscal 2025?
Rapid Micro Biosystems' diluted EPS was -$1.05 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Rapid Micro Biosystems generate in fiscal 2025?
Rapid Micro Biosystems generated -$31.9M of free cash flow in fiscal 2025.
What was Rapid Micro Biosystems' revenue last quarter?
In its most recent reported quarter (2026 Q2), Rapid Micro Biosystems reported revenue of $8.1M.
How much debt does Rapid Micro Biosystems have?
Rapid Micro Biosystems reported $18.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Rapid Micro Biosystems are outstanding?
Rapid Micro Biosystems reported a weighted average of 48.3 million basic shares outstanding in 2026 Q2.
What is Rapid Micro Biosystems' market cap?
Based on its latest closing price, Rapid Micro Biosystems (RPID) has a market capitalization of about $42.3M.
When does Rapid Micro Biosystems' fiscal year end?
Rapid Micro Biosystems' fiscal year end, as registered with the SEC, is December 31.
Where is Rapid Micro Biosystems headquartered?
Rapid Micro Biosystems lists its business address in Lexington, Massachusetts in its SEC filings.